A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has obtained promising results with patients who have acute myeloid leukemia that has not responded well to prior standard treatments.
Acute myeloid leukemia (AML) is a blood cancer characterized by rapid growth of abnormal white blood cells most commonly found in older patients; the average age of a patient with AML is 67, and the five-year survival rate is only 27 percent. It is a serious disease with very few treatment options and the standard of care has not changed much in decades. Survival is especially low in older AML patients who are less able to tolerate aggressive chemotherapy. Reducing side effects to normal tissues and limiting unsuccessful treatment attempts are therefore major concerns in the treatment of these patients.
Study Illuminates How Nutrients Control Glucagon Levels and Sheds Light on Future Diabetes Therapies
Researchers have known for some time that alterations in secretion of the hormone glucagon from the pancreas play a major role in diabetes. At the same time, defective glucagon secretion can lead to hypoglycemia in people with diabetes, but how it happens has remained largely a mystery. That is, until now.
A surgical oncologist at Sylvester Comprehensive Cancer Center of the University of Miami Miller School of Medicine has found that a simple procedure dramatically reduces lymphedema, a long-term swelling of the arm, after the removal of lymph nodes in breast cancer patients. This technique “lowers the rate of lymphedema from nearly one in five patients to just 3 percent.” said Eli Avisar, M.D.
The V Foundation for Cancer Research, a top-rated cancer research charity founded by ESPN and Jim Valvano, has announced a collaboration with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, the Miami Dolphins, and ESPN to support important cancer research.
As part of the Florida Firefighter Cancer Initiative, experts at Sylvester Comprehensive Cancer Center examined survey responses from 2,399 firefighters statewide about cancer and prevention practices. The findings were published as a Research Letter online in the Journal of the American Medical Association (JAMA) Dermatology.
Camillo Ricordi, M.D., director of the Diabetes Research Institute at the University of Miami Miller School of Medicine, has been named a Fellow of the National Academy of Inventors (NAI). Election to NAI Fellow status is the highest professional accolade bestowed solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions.